Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Submitted by
admin
on February 9, 2015 - 8:26am
Source:
Seeking Alpha
News Tags:
Achillion
hepatitis C
ACH-3102
Gilead Sciences
Sovaldi
Headline:
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Do Not Allow Advertisers to Use My Personal information
